跳至主要内容
临床试验/NL-OMON28586
NL-OMON28586已完成不适用

Distress and quality of life of patients treated with autologous stem cell transplantation following high-dose chemotherapy: outcome of stepped care.

Inholland University, Research Group Mental Health Nursing, Amsterdam, the NetherlandsVU University Medical Center, Amsterdam, the Netherlands0 个研究点目标入组 128 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
128

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients with hematological malignancy (multiple myeloma, (relapsed) (non-)Hodgkin lymphoma, acute myeloid leukemia, or acute lymphoid leukemia) treated with autologous stem cell transplantation following high-dose chemotherapy;
  • 2. Life expectation > 3 months.

排除标准

  • 1. Age < 18 or > 65 years (65 is included);
  • 2. Insufficient command of the Dutch language to complete questionnaires; or, if so: no support by family or professional interpreters;

研究者

发起方
Inholland University, Research Group Mental Health Nursing, Amsterdam, the NetherlandsVU University Medical Center, Amsterdam, the Netherlands

相似试验